About Roche Canada
Patients and science are at the heart of everything we do. Our passion for science and our commitment to relentlessly pursuing the impossible for patients have made us one of the world’s leading pharmaceutical, in vitro diagnostics, and healthcare technology companies.
We are passionate about advancing science – no matter where it comes from. We identify the best innovations, whether it’s ours or not, in order to help patients. Only by partnering with the brightest minds in science and healthcare, can we serve patients with difficult-to-treat diseases, both now and in future.
By collaborating, we’re doing what is best for patients and to create sustainable systems. Together, we go farther, faster. Roche Canada is committed to being a trusted partner to the hemophilia community, and are focused on bringing rapid, broad and sustainable treatment options to all people with hemophilia A.
Humanitarian Aid Program
Roche is pleased to be a member of the World Federation of Hemophilia (WFH) Humanitarian Aid Program, a landmark initiative aimed at addressing and improving access to treatment in developing countries.
As part of our commitment to bring sustainable solutions to the hemophilia community, Roche is collaborating with WFH to provide consistent and predictable access to preventative and on-demand treatment to as many as 1,000 people with bleeding disorders where there is little or no access to treatment. Roche also provides the training and expertise with local countries to ensure they can administer and monitor the donated product. To learn more about this initiative, please visit:www.roche.com/stories/haemophilia-treatment-for-all
For more information, please visit www.rochecanada.com
Patient Support Program
Launched in 2018, the EasyStart program for Hemlibra offers support for patients living with hemophilia A (congenital factor VIII deficiency) with factor VIII inhibitors.
Based on the assessment from their prescribers, patients enrolled in the Easy Start program are able to receive some or all of the following services as required:
Welcome kit, which includes:
- Starting HEMLIBRA brochure
- Instructions for use
- My HEMLIBRA injection log
- HEMLIBRA video access card
- Magnet
- In home or virtual injection training services from a certified nurse.
- Free of charge ancillary supplies throughout their treatment, such as safety needles, transfer needles,1 ML syringes, 3 ML syringes, sharps containers, Softa swabs, cotton gauzes and bandages. Additional supplies are ordered and shipped to patients automatically so that you always have them available.
- Opt into automated SMS or email injection reminders, based on the date and time when the patient or their caregiver(s) would like to receive them.
- Translation line services to assist patients who speak languages other than English or French.
The EasySTART program’s contact information is as follows:
Tel: 1-833-582-7904
Fax: 1-833-582-7903
Email: info@easystartRPAP.com
